These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30861262)

  • 1. The effect of increased frequency of hemodialysis on serum cystatin C and β2-microglobulin concentrations: A secondary analysis of the frequent hemodialysis network (FHN) trial.
    Huang SS; Kaysen GA; Levin NW; Kliger AS; Beck GJ; Rocco MV; Filler G; Lindsay RM;
    Hemodial Int; 2019 Jul; 23(3):297-305. PubMed ID: 30861262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials.
    Raimann JG; Chan CT; Daugirdas JT; Depner T; Greene T; Kaysen GA; Kliger AS; Kotanko P; Larive B; Beck G; Lindsay RM; Rocco MV; Chertow GM; Levin NW;
    Kidney Blood Press Res; 2021; 46(6):768-776. PubMed ID: 34644706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solute clearances and fluid removal in the frequent hemodialysis network trials.
    Greene T; Daugirdas JT; Depner TA; Gotch F; Kuhlman M; ; ;
    Am J Kidney Dis; 2009 May; 53(5):835-44. PubMed ID: 19339093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of increased frequency of hemodialysis on vitamin C concentrations: an ancillary study of the randomized Frequent Hemodialysis Network (FHN) daily trial.
    Raimann JG; Abbas SR; Liu L; Larive B; Beck G; Kotanko P; Levin NW; Handelman G;
    BMC Nephrol; 2019 May; 20(1):179. PubMed ID: 31101018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
    Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
    Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.
    Rocco MV; Larive B; Eggers PW; Beck GJ; Chertow GM; Levin NW; Kliger AS;
    Am J Kidney Dis; 2011 Jan; 57(1):90-100. PubMed ID: 21122961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of extra renal clearance and generation rate of beta2-microglobulin in hemodialysis patients using a kinetic model.
    Xu XQ; Gruner N; Al-Bashir A; Trutt-Ibing CH; Melzer H; Fassbinder W; Stiller JS; Manm H
    ASAIO J; 2001; 47(6):623-7. PubMed ID: 11730200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials.
    Chan CT; Kaysen GA; Beck GJ; Li M; Lo JC; Rocco MV; Kliger AS;
    Hemodial Int; 2020 Apr; 24(2):162-174. PubMed ID: 31826326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.
    Rocco MV; Daugirdas JT; Greene T; Lockridge RS; Chan C; Pierratos A; Lindsay R; Larive B; Chertow GM; Beck GJ; Eggers PW; Kliger AS;
    Am J Kidney Dis; 2015 Sep; 66(3):459-68. PubMed ID: 25863828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal hemodialysis: analysis following the Frequent Hemodialysis Network trial.
    Stokes JB
    Semin Dial; 2011; 24(6):614-20. PubMed ID: 22122449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.
    Chan CT; Greene T; Chertow GM; Kliger AS; Stokes JB; Beck GJ; Daugirdas JT; Kotanko P; Larive B; Levin NW; Mehta RL; Rocco M; Sanz J; Schiller BM; Yang PC; Rajagopalan S;
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):251-61. PubMed ID: 22360996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis.
    Kabanda A; Jadoul M; Pochet JM; Lauwerys R; van Ypersele de Strihou C; Bernard A
    Kidney Int; 1994 Jun; 45(6):1689-96. PubMed ID: 7933817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Treatment Duration and Frequency on Uremic Solute Kinetics, Clearances and Concentrations.
    Leypoldt JK; Meijers BK
    Semin Dial; 2016 Nov; 29(6):463-470. PubMed ID: 27578429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
    Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
    G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis.
    Lo JC; Beck GJ; Kaysen GA; Chan CT; Kliger AS; Rocco MV; Chertow GM;
    Hemodial Int; 2017 Apr; 21(2):190-196. PubMed ID: 27774730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum beta2-microglobulin in hemodialyzed patients.
    Vincent C; Revillard JP; Galland M; Traeger J
    Nephron; 1978; 21(5):260-8. PubMed ID: 82208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules.
    Park JS; Kim GH; Kang CM; Lee CH
    Korean J Intern Med; 2010 Mar; 25(1):77-81. PubMed ID: 20195407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cystatin C and Beta-2-microglobulin kinetics in children on maintenance hemodialysis.
    Marsenic O; Wierenga A; Wilson DR; Anderson M; Shrivastava T; Simon GA; Beck AM; Swanson TJ; Studnicka K; Elberg D; Singh NS; Couloures K; Henry D; Turman MA
    Hemodial Int; 2013 Oct; 17 Suppl 1():S11-6. PubMed ID: 24134324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of cystatin C in low- and high-flux hemodialysis in children with end-stage renal disease.
    Fadel FI; Mourad AA; Abdel Rahman AMO; Bazaraa HM; Mohamed MF; El-Lebedy DH; Soliman MM
    Pediatr Nephrol; 2017 Sep; 32(9):1603-1609. PubMed ID: 28417217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.